has co-sponsored a consensus conference on Lyme disease at which recommendations pertaining to epizootiology, epidemiology, clinical practice and laboratory investigation of Lyme disease were drafted (4). The Bureau of Communicable Disease Epidemiology, LCDC, maintains data on human Lyme disease cases occurring in Canada, and the Zoonotic Diseases section, National Laboratory for Special Pathogens of the Bureau of Microbiology, LCDC, provides laboratory support. This laboratory support includes collaborative investigations to determine the distribution of B burgdorjeri in Canada, identification of ticks submitted, initiation of a joint venture to produce a manual on the identification and distribution of ticks in Canada, proficiency testing of provincial public health laboratories, provision of reference testing and evaluation of commercial products.
Three proficiency tests have been conducted from 1990-92 involving eight provincial public health laboratories. The serological tests reported included enzymelinked immunosorbent assay (ELISA) performed by all laboratories as well as immunofluorescent antibody (IFA) and Western Blot (WB) tests undertaken by some laboratories. The results confirmed that ELISA is a more reliable screening assay than the IFA test, although false positive and negative serologies were obtained. Overall, ELISA sensitivities ranged from 42.9 to 100%, with most sensitivities over 90%, and specificities ranged from 75 to 100%. The few laboratories reporting WB results had sensitivities ranging from 50 to 100% and specificities from 60 to 100%.
It has been recommended that WB be used by Canadian laboratories to confirm the presence of specific antibodies in sera found positive by ELISA testing (4). The performance of the WB as a confirmatory test has been disappointing to date. Between August 1990 and December 1992, one or more ELISA positive sera from 40 patients were tested at LCDC using a commercial WB test with the following results: nine (22.5%) negatives. nine (22.5%) positives and 22 (55.0%) indeterminates. Thus. WB was able to provide a clear resolution of reactivity in only 45% of these patients.
There are no standard criteria for the interpretation of the WB test for Lyme disease. Some laboratories simply look for four or more designated bands whereas other laboratories require a specific pattern of reactive bands , eg, reaction with the 41 k.Da flagellar protein band and at least one band corresponding to low molecular weight proteins of 18, 21.5 or 23 k.Da (9) . During infection there is an initial response to the 41 k.Da protein followed over several months by a variable graded response to a s many as 10 or more proteins. This delayed expression may be related to degradation of the structural integrity of the bacteria with resultant presentation of previously protected immunogenic constituents or perhaps due to increased suppressor cell activity. which has been demonstrated in early diseases may restrict the initial antibody response to the full spectrum of bacterial antigens (10) .
Despite these inherent problems in the Lyme disease WB test. this test may still play a useful role. Rose et al (11) examined patients' sera and showed that positive results from both WB and ELISA assays provided strong diagnostic support for Lyme disease whereas a positive E LISA with a negative WB was generally associated with a lack of clinical features of Lyme disease. Recently, Banerjee et al ( 12) used WB as a tool to demonstrate that !FA titres to B burgdor:feri and B hennsii in British Columbia patients were likely due to nonspecific reactions and to conclude that it is unlikely borreliosis is a causative factor for any chronic arthropathies seen in British Columbia.
There are several commercial WB kits available and the Zoonotic Diseases section is planning to undertake an evaluation of these products in the coming year to determine their relative merits. It is important not to 116 lose sight of the fact that diagnosis of Lyme disease requires appropriate clinical presentation with laboratory tests serving primarily as back up. Nevertheless. the recent isolation of B burgdor:feri from the apparently nonendemic province of Prince Edward Island (6) illustrates the importance of having appropriate tests to recognize the sporadic cases that may occur in Canada.
